1[1]Ichinohasama R,DeCotean JF,Myers J,et al.Three-color flow cytometry in the diagnosis of malignant lymphomabased on the comparative cell morphology of lymphoma cells and reactive lymphocytes[J].Leukemia,1997,11(11):1891-1903.
5[5]Bene MC,Bemier M.Casasnovas RO,et al.The reliability and specificity of C-kit for the diagnosis of acute myeloid leukemias and undifferentiated leukemias[J].Blood,1998,92(2):596-599.
6[6]Kaleem Z,Crawford E,Pathan MH,et al.Flow cytometric analysis of acute leukemias.Diagnostic utility and critieal analysis of data[J].Arch Pathol Lab Med,2003,127(1):42-48.
7[7]Yang DT,Greenwood JH,Hartung L,et al.Flow cytometric analysis of different CD14 epitopes can help identify immature monocytic populations[J].Am J Clin Pathol,2005,124(6):930-936.
8[8]Auewarakul CU,Promsuwicha O,U-Pratya Y,et al.Immunophenotypic profile of adult acute myeloid leukemia(AML):analysis of 267 cases in Thailand[J].Asian Pac J Allergy Immunol,2003,21(3):153-160.
9[9]Venditti A,Del PG,Buccisano F,et al.Minimally differentiated acute myeloid leukemia(AML-M0):comparison of 25 cases with other French-American-British subtypes[J].Blood,1997,89(2):621-629.
10[10]Mason KD,Juneja SK,Szer J.The immunophenotypic of acute myeloid leukemia:is there a relationship with prognosis[J].Blood Rev,2006,20(2):71-78.
4Lanza F, Latorraca A, Mocetti S, et al. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cell[J]. Cytometry, 1997,30:134-144.
5Lemez P. A more precise diagnosis of AML M0,apart of which-exhibits a near-teraploid karyotype['J]. Leukemia, 1999 ~ 13 : 145~ 146.
7Putti M C,Rondelli R,Cacito M G,et al. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastie leukemia.. Italian experience in AIEOP-ALL88-91 studies [J].Blood, 1998;92:795-801.
8Jennings DC, Foon KA. Recent advances in flow cytometry:application to the diagnosis of hematologic malignancy [J]. Blood, 1997,90:2863-2892.
9Nomdedeu JF, Mateu R, Altes A, et al. Enhanced myeloid specificity of CD117 compared with CD13 and CD33 [J]. Leuk Res, 1999,23:341-347.
